Antigenic relationships between sylvatic and endemic dengue viruses

Area of Science:

• * Virology
• * Immunology
• * Epidemiology

Background:

• * Sylvatic dengue viruses (DENVs) circulate in non-human primates and mosquitoes in Southeast Asia and West Africa.
• * Potential re-emergence of sylvatic DENV into urban cycles could impede eradication efforts using developing vaccines.
• * Understanding immunity to sylvatic strains is crucial for assessing vaccine efficacy and disease control.

Purpose of the Study:

• * To evaluate the neutralization capacity of human sera against sylvatic DENV strains.
• * To assess the impact of immunity from endemic DENV strains or vaccines on sylvatic DENV re-emergence.
• * To determine the likelihood of sylvatic DENV re-introduction into urban transmission cycles.

Main Methods:

• * Sera from individuals vaccinated against DENV or recovered from primary DENV-2 and DENV-3 infections were tested.
• * Neutralization capacity against sylvatic DENV strains was assessed using in vitro assays.
• * Homotypic and heterotypic cross-neutralization patterns were analyzed.

Main Results:

• * Human sera demonstrated strong homotypic cross-immunity against sylvatic DENV strains.
• * Limited heterotypic neutralization was observed, indicating serotype-specific immune responses.
• * Existing immunity provides a significant barrier to sylvatic DENV re-emergence in urban settings.

Conclusions:

• * Homotypic immunity, induced by prior infection or vaccination, effectively neutralizes sylvatic DENV strains.
• * Should urban transmission be eradicated, pre-existing immunity will likely restrict the re-emergence of sylvatic DENV strains.
• * Virus-neutralizing antibodies play a key role in preventing sylvatic DENV re-introduction into human populations.